Total Clarity Wealth Management, Inc. Pds Biotechnology Corp Transaction History

Total Clarity Wealth Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$5.68 - $11.99 $15,602 - $32,936	-2,747 Reduced 16.06%	14,362 $88,000
Q4 2022 Feb 03, 2023	BUY	$3.28 - $13.2 $56,117 - $225,838	17,109 New	17,109 $225,000
Q2 2022 Jul 29, 2022	BUY	$3.05 - $6.68 $11,525 - $25,243	3,779 New	3,779 $14,000
Q1 2022 Apr 29, 2022	SELL	$4.78 - $8.43 $63,602 - $112,169	-13,306 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$7.76 - $14.35 $25,887 - $47,871	-3,336 Reduced 20.05%	13,306 $108,000
Q3 2021 Oct 21, 2021	BUY	$9.33 - $17.08 $155,269 - $284,245	16,642 New	16,642 $248,000
Q2 2021 Jul 26, 2021	SELL	$4.35 - $12.86 $6,524 - $19,290	-1,500 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$2.28 - $6.81 $3,419 - $10,215	1,500 New	1,500 $7,000

4.05M

253K

70.4K

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $46.1M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.